ClinicalTrials.gg
RecruitingNCT05859451Updated Dec 11, 2024

Effect of Tobacco Heating System (THS) on Closed Lower Limb Fracture Healing

An interventional study of Tobacco Heating System (THS) and Smoking abstinence in Smoking and Tibia Fracture, sponsored by University Hospital Tuebingen. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by University Hospital Tuebingen · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to investigate the role of switching from cigarette smoking (CS) to tobacco heat system (THS) on the clinical outcome of closed lower limb (tibia and femur) fractures from smokers' orthopedic patients. Validated and standardized assays, medical state and self-reported outcomes will be evaluated in orthopedic patients' smokers or switch from CS to using THS throughout six months compare to ex-smokers (control).

02

Conditions studied

  • Smoking
  • Tibia Fracture

Keywords

  • Bone healing
  • Tobacco heating system
  • Smoking cessation
03

In context

Smoking

325 studies on the registry are indexed under Smoking; 141 are open to participants now.

This study's planned enrollment of 150 is above the median of 117 across 250 interventional studies indexed under Smoking.

Browse Smoking studies →

Lead sponsor

University Hospital Tuebingen is the lead sponsor of 490 studies on the registry; 108 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Closed tibia or femur fracture (according to AO/OTA: 41A2-41C3, 42A-C, 43A-C, 32A-C, 33A2-3, 33B-C) which is surgically treated within 14 days after the trauma at the BG trauma clinic Tübingen.

Additional inclusion criteria for the smoking and THS groups:

  • Smokers with 10-20 packyears smoking history.
  • Smoking history >10 years.
  • Decision not to participate in the free smoking cessation seminars.

Exclusion criteria

Exclusion Criteria:

  • Legal guardian or loss of capacity to consent.
  • Refusal to participate in the study.
  • Open fractures or concomitant injuries or complications requiring surgery existing at the time of surgical indication.
  • Initial surgical treatment of the fracture has occurred ex domo.
  • No initial surgical treatment within 14 days of sustained trauma.
  • Using nicotine delivery electronic devices.
  • Pre-existing autoimmune, immunological, bone or malignant diseases.
  • Pregnant, breastfeeding and women of childbearing age with existing desire to have children.
  • History of alcohol abuse or drug abuse.
  • Taking antioxidants approval by the German Federal Institute for Drugs and Medical Devices (BfArM).
  • Taking drugs with known effect on bone metabolism (according to Institute for medical and pharmaceutical examination issues (IMPP): allosteric CaSR modulators, bisphosphonates, calcium release inhibitors, alkaline earth ions, RANKL inhibitors, calcitriol, colecalciferol).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • No intervention
    Smokers

    Participants subject to an orthopedic surgery (does not want to quit smoking conventional cigarettes) will continue smoking conventional cigarettes ad libitum for a period of 6 month post surgery

  • Experimental
    Smokers willing to switch to THS

    Participants subject to an orthopedic surgery (currently smoking conventional cigarettes) will start to used THS ad libitum for a period of 6 month post surgery

    Device: Tobacco Heating System (THS)

  • Active comparator
    Ex Smokers

    Participants subject to an orthopedic surgery will not smoke cigarettes or use electronic nicotine deliver systems for a period of 6 month post surgery

    Other: Smoking abstinence

Interventions

  • DeviceTobacco Heating System (THS)

    Participant who are not willing to quit cigarette smoking during the study duration will switch from cigarettes to using THS

    Also known as: IQOS 3 DUO

  • OtherSmoking abstinence

    Participant who are willing to quit cigarette smoking and will not use any electronic nicotine delivery system during the study duration

06

What researchers measure

Primary outcomes

  1. Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP)

    Marker collagen formation - bone formation

    Time frame: 6 months after tibia fracture surgery

Secondary outcomes

  1. Concentration of Alkaline Phosphatase (BAP)

    Marker osteoblast activity

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  2. Concentration of Osteoprogesterin

    Decoy receptor RANKL - inhibit osteoclast differentiation

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  3. Concentration of Osteopontin

    Extracellular structural protein and an organic component of bone - favors osteoclast adherence

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  4. Concentration of N-terminal telopeptide (NTx)

    Marker collagen degradation - bone resorption

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  5. Concentration of Interleukin 1 beta (IL-1β)

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  6. Concentration of Interleukin 6 (IL-6)

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  7. Concentration of Interferon gamma (IFN-γ)

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  8. Concentration of Tumor Necrosis Factor Alpha (TNF-α)

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  9. Number of bridged cortices in conventional X-ray

    Time frame: 6 months after tibia fracture surgery

  10. Number of bridged cortices in computed tomography scan

    Time frame: 6 months after tibia fracture surgery

  11. Bone Stiffness by a CT-based finite element method

    Finite element method will be used to simulate the mechanical behavior (linear-elastic range) of the tibia and predict bending stiffness under a 3-point bending test

    Time frame: 6 months after tibia fracture surgery

  12. Functional index in trauma (FIX-IT) - Score

    Assess weight-bearing and pain in patients with lower extremity fractures eight-bearing and pain in patients with lower extremity fractures. The score rank from 0 to 12 points in 2 domains: the ability to bear weight (maximum 6 points) and pain at the fracture site (maximum 6 points). The scores in both domains, which are weighted equally, are summed to obtain the final total score; (maximum 12 points indicates the highest level of function).

    Time frame: 6 months after tibia fracture surgery

  13. Loading of the injured extremity

    The time period with no, sole contact, partial or full load on the injured extremity.

    Time frame: 6 months after tibia fracture surgery

  14. Lower Extremity Functional Scale (LEFS) - Score

    The Lower Extremity Functional Scale (LEFS) is a questionnaire (20 questions) about a person's ability to perform everyday tasks. The LEFS will be used to evaluate the functional impairment of a patient with a disorder of lower extremity. The score rank from 0 to 80 points. The maximum score (80 point) indicates no functional limitations.

    Time frame: 6 months after tibia fracture surgery

  15. Number of complications associated with the healing process

    Time frame: 6 months after tibia fracture surgery

  16. Number of hospital stay and incapacity to work [days]

    Time frame: 6 months after tibia fracture surgery

  17. Physicians Global Assessment to measure quality of life (PROMIS GH10 v 1.2) - Score

    The Global Health Patient-Reported Outcomes Measurement Information System (PROMIS- 10) scale is a ten-item patient reported measure of physical, mental and social health. Two summary scores are calculated from the results of the questions: a global physical health score and a global mental health score. These scores are then normalized to the general population using the "T-score." The score ranges from 0 to 20 points. 0 points represent the most severe physical and/or mental impairment of the patient, while 20 points represent the best possible health status.

    Time frame: 6 months after tibia fracture surgery

  18. Visual Analog Score for pain (VAS) - Score

    Visual Analog Scale for Pain (VAS) provide an estimate of patients' pain intensity. Scale from cero (no pain) to 10 (extreme pain).

    Time frame: 6 months after tibia fracture surgery

Other outcomes

  1. Concentration of Soluble intercellular adhesion molecule-1 (sICAM-1)

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  2. Concentration of High densitiy lipoprotein cholesterol levels (HDL)

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  3. Concentration of Leucocytes

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  4. Concentration of Erythrocytes

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  5. Concentration of Hemoglobin

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  6. Concentration of Thrombocytes

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  7. Mean corpuscular volume

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  8. Hematocrit levels

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  9. Mean corpuscular hemoglobin levels

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  10. Corpuscular hemoglobin concentration

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  11. Protein c reactive levels

    Time frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  12. Alcohol consume

    Compensation cigarette abstinence with alcohol

    Time frame: 6 months after tibia surgery

  13. Questionnaire on Smoking Urges (QSU-G) - Score

    Time frame: 6 months after tibia surgery

  14. Smoking behaviour

    Number of cigarettes or THS heets consume

    Time frame: 6 months after tibia surgery

  15. Nicotine withdrawal syndrome assessment - Checklist

    Time frame: 6 months after tibia surgery

07

Study locations

1 of 1 sites recruiting
  • Siegfried Weller Institutes, BG-Trauma Clinic, Department of Traumatology, Eberhard Karls University Tübingen
    Tübingen, Baden-Wurttemberg 72076, Germany
    • Andreas K. Nüssler, Prof. Dr. · Contact · andreas.nuessler@med.uni-tuebingen.de · +49070716061065
    • Benedik J. Braun, PD. Dr. med. · Contact · bbraun@bgu-tuebingen.de · +49070716063017
    • Andreas K. Nüssler, Prof. Dr. · Principal investigator
    • Benedik J. Braun, PD. Dr. med. · Sub investigator
    • Romina H. Aspera-Werz, Dr. sc. hum. · Sub investigator
    Recruiting
08

References and documents

Publications

  • Aspera-Werz RH, Ehnert S, Muller M, Zhu S, Chen T, Weng W, Jacoby J, Nussler AK. Assessment of tobacco heating system 2.4 on osteogenic differentiation of mesenchymal stem cells and primary human osteoblasts compared to conventional cigarettes. World J Stem Cells. 2020 Aug 26;12(8):841-856. doi: 10.4252/wjsc.v12.i8.841. PubMed 32952862 ↗
  • Weng W, Bovard D, Zanetti F, Ehnert S, Braun B, Uynuk-Ool T, Histing T, Hoeng J, Nussler AK, Aspera-Werz RH. Tobacco heating system has less impact on bone metabolism than cigarette smoke. Food Chem Toxicol. 2023 Mar;173:113637. doi: 10.1016/j.fct.2023.113637. Epub 2023 Jan 25. PubMed 36708864 ↗
  • Moritz Herbst, Romina Aspera-Werz, Benedikt Braun, Kevin Schulz, et al. (2024). Evaluation of the Tobacco Heating System (THS) During Closed Lower Limb Fracture Healing in Trauma Smokers' Patients. Qeios. doi:10.32388/DE0EAE.2.

Individual participant data

Plan to share: Yes — All IPD (in an anonymous form) that underlie results in a publication

Supporting information: Study protocol

Time frame: 6 months after results are published in peer-reviewed international journal

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05859451
Responsible party
Prof. Dr. rer. nat. Andreas Nüssler (Profesor Doctor, University Hospital Tuebingen) — Principal investigator
First posted
May 16, 2023
Start date
Jun 2, 2023
Primary completion
Oct 15, 2025 (estimated)
Completion
Apr 17, 2026 (estimated)
Last update
Dec 11, 2024

Study contacts

Andreas K. Nüssler, Prof. Dr.
Contact
andreas.nuessler@med.uni-tuebingen.de
+49070716061065
Benedikt J. Braun, PD. Dr.
Contact
bbraun@bgu-tuebingen.de
+49070716063017

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion